What amount sold does Optima Healthcare & Biotech Fund Ltd report in Form D filings?

The latest linked filings report $18.4M sold across 1 identified offering(s). 1 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Optima Healthcare & Biotech Fund Ltd's most recent SEC filing?

Optima Healthcare & Biotech Fund Ltd's most recent Form D filing was on 2026-01-21.

How many investors does Optima Healthcare & Biotech Fund Ltd have?

The most recent Form D filing lists 20 investor(s).

Optima Healthcare & Biotech Fund Ltd

CIK: 0001799805·Pooled Investment Fund·HAMILTON, D0

Reported Sold

$18,393,533

Total Filings

Identified Offerings

Last Filed

Jan 21, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 1 unlinked amendment excluded.

Offering filing timeline

Jan 21, 2026Form D/A — Amendment

Reported sold: $20,968,266 · Target: N/A

No verified predecessor available.

Rule 506(c)·20 investors·Section 3(c), Section 3(c)(7)

Nov 26, 2024Form D/A — Amendment

Reported sold: $18,393,533 · Target: Indefinite

Rule 506(c)·20 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold

Nov 29, 2023Form D/A — Amendment

Reported sold: $18,268,533 · Target: Indefinite

Rule 506(c)·20 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold

Nov 28, 2022Form D/A — Amendment

Reported sold: $18,168,533 · Target: Indefinite

Rule 506(c)·20 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Jan 6, 2022Form D/A — Amendment

Reported sold: $17,518,616 · Target: Indefinite

Rule 506(c)·21 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Jan 11, 2021Form D/A — Amendment

Reported sold: $10,538,586 · Target: Indefinite

Rule 506(c)·11 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Jan 14, 2020Form D — New notice

Reported sold: $2,000,000 · Target: Indefinite

Rule 506(c)·6 investors·Section 3(c), Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

86%

Latest reported sold across 1 identified offering

$18,393,533

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

1 unlinked amendment excluded.

Key People

Optima Asset Management LLC

Promoter

Appears on 7 filings

Geoffrey Manfred Lewis

Director

Appears on 7 filings

Thomas Haskins Davis

Director

Appears on 6 filings

Neil Glass

Director

Appears on 6 filings

Thomas Haskins Davis

Related Person

Appears on 1 filing

Neil Glass

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 21, 2026	Amendment	N/A	$20,968,266	20
Nov 26, 2024	Amendment	Indefinite	$18,393,533	20
Nov 29, 2023	Amendment	Indefinite	$18,268,533	20
Nov 28, 2022	Amendment	Indefinite	$18,168,533	20
Jan 6, 2022	Amendment	Indefinite	$17,518,616	21
Jan 11, 2021	Amendment	Indefinite	$10,538,586	11
Jan 14, 2020	New	Indefinite	$2,000,000	6

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Maple Leaf Fund Ltd.

Pooled Investment Fund

Offering target: Indefinite

Filed Oct 21, 2026